Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 13/20 | 0.72 |
| ▸ | CNR1 | P21554 | 11/20 | 0.72 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.37 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.37 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.37 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.37 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.37 |
| ▸ | HTR2A | P28223 | 1/20 | 0.37 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.37 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.37 |
| ▸ | CYP2J2 | P51589 | 1/20 | 0.37 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.37 |
| ▸ | TRPV3 | Q8NET8 | 1/20 | 0.37 |
| ▸ | TRPV4 | Q9HBA0 | 1/20 | 0.37 |
| ▸ | TRPV2 | Q9Y5S1 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11738348 | 0.86 | CNR2 (0.71) | CNR2CNR1MEN1GAAKMT2A | |
| SCHEMBL4537590 | 0.84 | CNR2 (1.00) | CNR2CNR1MEN1GAAKMT2A | |
| SCHEMBL31103617 | 0.84 | CNR2 (1.00) | CNR2CNR1MEN1GAAKMT2A | |
| SCHEMBL5090381 | 0.84 | CNR2 (1.00) | CNR2CNR1MEN1GAAKMT2A | |
| SCHEMBL1114914 | 0.83 | CNR2 (0.98) | CNR2CNR1MEN1GAAKMT2A | |
| SCHEMBL16124349 | 0.81 | CNR2 (0.94) | CNR2CNR1MEN1GAAKMT2A | |
| SCHEMBL11757291 | 0.74 | CNR2 (0.82) | CNR2CNR1MEN1GAAKMT2A | |
| SCHEMBL31545082 | 0.73 | CNR2 (0.81) | CNR2CNR1MEN1GAAKMT2A | |
| SCHEMBL25981698 | 0.73 | CNR2 (0.80) | CNR2CNR1MEN1GAAKMT2A | |
| SCHEMBL22783274 | 0.71 | CNR2 (0.78) | CNR2CNR1MEN1GAAKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12371412-B2 | Methods of preparing cannabinoids or derivatives thereof | FLORASCIENCE INC. (US) | 2025-07-29 | — | — | US | disclosed |
| US-20250214957-A1 | METHODS OF PREPARING CANNABINOIDS OR DERIVATIVES THEREOF | FLORASCIENCE INC. | 2025-07-03 | — | — | US | disclosed |
| US-12281091-B1 | Methods of preparing cannabinoids or derivatives thereof | FLORASCIENCE INC. (US) | 2025-04-22 | — | — | US | disclosed |
| US-20250009765-A1 | COMPOSITIONS AND METHODS FOR REDUCING SLEEP DISTURBANCES AND TREATING SLEEP DISORDERS | FLORASCIENCE INC (US) | 2025-01-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250009765-A1 | COMPOSITIONS AND METHODS FOR REDUCING SLEEP DISTURBANCES AND TREATING SLEEP DISORDERS | CNR2, CNR1, PER2 | CNR2 1/4885CNR1 2/4885MEN1 2609/4885 |
| US-12281091-B1 | Methods of preparing cannabinoids or derivatives thereof | CNR2, CNR1, FAAH | CNR2 1/4885CNR1 2/4885MEN1 2345/4885 |
| US-20250214957-A1 | METHODS OF PREPARING CANNABINOIDS OR DERIVATIVES THEREOF | CNR2, CNR1, FAAH | CNR2 1/4885CNR1 2/4885MEN1 2345/4885 |
| US-12371412-B2 | Methods of preparing cannabinoids or derivatives thereof | CNR2, CNR1, FAAH | CNR2 1/4885CNR1 2/4885MEN1 2345/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.